Hemorrhagic Fevers, Viral clinical trials

The registry lists 38 studies for Hemorrhagic Fevers, Viral across more than 10 countries. 6 are recruiting or about to start. 12 of them are mainly about Hemorrhagic Fevers, Viral (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-05. Counting its 4 narrower conditions too, such as Dengue: 454 studies, 69 open.

Get an email when these change. Save the Hemorrhagic Fevers, Viral studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 22
Recruiting: 4
Terminated: 4
Suspended: 3
Not yet recruiting: 2
Status unknown: 2

Phase

Phase 2: 15
Phase 1: 12
Phase 3: 6

Where

United States: 15
Uganda: 5
Nigeria: 4
Kenya: 4
Russian Federation: 3
Tanzania: 3

Who runs them

National Institute of Allergy and Infectious Diseases (NIAID) (7) · U.S. Army Medical Research and Development Command (5) · Janssen Vaccines & Prevention B.V. (4) · Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation (3) · Cepheid (2) · University of Maryland, Baltimore (2) · Emergent BioSolutions (2) · International AIDS Vaccine Initiative (1)

What is being tested here

Drugs under test in Hemorrhagic Fevers, Viral studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Dexamethasone	2	2	2
Ribavirin	1	1	4
Favipiravir	1	1	2
ARN-75039	1	1	2
Acetylcysteine	1	1	1
Baricitinib	1	1	1
Remdesivir	0	1	1
Ansuvimab	0	1	1
AT-752	0	0	1

Coming up

3phase 3 studies under way

4studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4, phase 3 first

Apr 2027Study of Vaccines Against Bundibugyo Virus Disease in Contacts of Cases in the Democratic Republic of the Congo · Phase 3 · Jean-Pierre Van geertruyden
Jun 2027ISTH/ANRS 0409s INTEGRATE Lassa Fever Study · Phase 3 · Irrua Specialist Teaching Hospital
Apr 2027A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health · International AIDS Vaccine Initiative
May 2027RVF and Other Emerging Infectious Diseases in East and Central Africa · Washington State University

Who these studies take

Of the 4 Hemorrhagic Fevers, Viral studies recruiting now, 3 (75%) set no upper age limit and 1 (25%) stop at 75 or younger. 2 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (50%) take healthy volunteers.

Recruiting studies that take each age, of 4
Age	Women	Men
10	2 (50%)	2 (50%)
18	4 (100%)	4 (100%)
30	4 (100%)	4 (100%)
40	4 (100%)	4 (100%)
50	4 (100%)	4 (100%)
65	3 (75%)	3 (75%)
75	3 (75%)	3 (75%)
85	3 (75%)	3 (75%)

Across all 38 studies, recruiting or not: 61% stop at 75 or younger and 53% at 65; 37% take children; 0% are for women only and 0% for men only; 71% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 38 of 38. search them.